Current liabilities increased 28.6%
Current liabilities changed +28.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$2.2B→$2.8B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →EMN financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 13.8%
Trade receivables changed +13.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$933.0M→$1.1B4 prior comparisons
Operating cash flow decreased 27.9%
Operating cash flow changed -27.9% from the comparable as-filed period.
$402.0M→$290.0M2 prior comparisons
Free-cash-flow proxy decreased 26.4%
Free-cash-flow proxy changed -26.4% from the comparable as-filed period.
$265.0M→$195.0M2 prior comparisons
Net income increased 436.2%
Net income changed +436.2% from the comparable as-filed period.
$47.0M→$252.0M2 prior comparisons
Gross margin moved 264 bp higher
Gross margin changed +264 basis points from the comparable as-filed period.
19.66%→22.31%2 prior comparisons
Inventory / revenue moved 369 bp higher
Inventory / revenue changed +369 basis points from the comparable as-filed period.
87.97%→91.66%2 prior comparisons
Short-term borrowings increased 122.4%
Short-term borrowings changed +122.4% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$344.0M→$765.0M4 prior comparisons
Free-cash-flow proxy increased 49.4%
Free-cash-flow proxy changed +49.4% from the comparable as-filed period.
$83.0M→$124.0M3 prior comparisons
Inventory / revenue moved 1045 bp lower
Inventory / revenue changed -1045 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
94.05%→83.61%2 prior comparisons
Trade receivables increased 11.0%
Trade receivables changed +11.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$988.0M→$1.1B4 prior comparisons
Current liabilities increased 19.0%
Current liabilities changed +19.0% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$2.4B→$2.8B4 prior comparisons
Net income increased 30.7%
Net income changed +30.7% from the comparable as-filed period.
$140.0M→$183.0M2 prior comparisons
Capex / revenue moved 258 bp lower
Capex / revenue changed -258 basis points from the comparable as-filed period.
6.56%→3.98%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.